BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33991540)

  • 21. Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003-2013.
    Wang SS; Kotecha RS; Bernard A; Blyth CC; McMullan BJ; Cann MP; Yeoh DK; Bartlett AW; Ryan AL; Moore AS; Bryant PA; Clark J; Haeusler GM
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27915. PubMed ID: 31309711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
    Arikan K; Aytac S; Büyükcam A; Cengiz AB; Cetinkaya FD; Cetin M; Ozsurekci Y; Ceyhan M; Kara A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e613-e618. PubMed ID: 33560081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years.
    Avcu G; Karadas N; Goktepe SO; Bal ZS; Metin DY; Polat SH; Aydinok Y; Karapinar DY
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):392-397. PubMed ID: 37526370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.
    Lin GL; Chang HH; Lu CY; Chen CM; Lu MY; Lee PI; Jou ST; Yang YL; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2018 Apr; 51(2):251-259. PubMed ID: 28089099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients.
    Lehrnbecher T; Fisher BT; Phillips B; Beauchemin M; Carlesse F; Castagnola E; Duong N; Dupuis LL; Fioravantti V; Groll AH; Haeusler GM; Roilides E; Science M; Steinbach WJ; Tissing W; Warris A; Patel P; Robinson PD; Sung L
    J Clin Oncol; 2020 Sep; 38(27):3205-3216. PubMed ID: 32459599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
    Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
    Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation.
    Perez P; Patiño J; Franco AA; Rosso F; Beltran E; Manzi E; Castro A; Estacio M; Valencia DM
    Blood Res; 2022 Mar; 57(1):34-40. PubMed ID: 35256547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
    Hol JA; Wolfs TF; Bierings MB; Lindemans CA; Versluys AB; Wildt de A; Gerhardt CE; Boelens JJ
    Bone Marrow Transplant; 2014 Jan; 49(1):95-101. PubMed ID: 24121212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.
    El Cheikh J; Ceballos P; Dalle JH; Ducastelle-Leprêtre S; Dulon E; Herbrecht R
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):268-273. PubMed ID: 30842034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
    Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
    Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
    Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W
    Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.